Polymorphism rs2073618 of the TNFRSF11B (OPG) Gene and Bone Mineral Density in Mexican Women with Rheumatoid Arthritis.
C A Nava-ValdiviaA M Saldaña-CruzEsther Guadalupe Corona-SánchezJ D Murillo-VazquezMaria Cristina Moran-MoguelMario Salazar-PáramoE E Perez-GuerreroM L Vazquez-VillegasD Bonilla-LaraAlberto Daniel Rocha-MuñozBeatriz-Teresita Martín-MárquezF Sandoval-GarciaErika Aurora Martínez-GarcíaNicte S Fajardo-RobledoJ M Ponce-GuarnerosM Ramirez-VillafañaM F Alcaraz-LopezGonzalez-Lopez LauraJorge Ivan Gamez-NavaPublished in: Journal of immunology research (2017)
Osteoporosis (OP) is highly prevalent in rheumatoid arthritis (RA) and is influenced by genetic factors. Single-nucleotide polymorphism (SNP) rs2073618 in the TNFRSF11B osteoprotegerin (OPG) gene has been related to postmenopausal OP although, to date, no information has been described concerning whether this polymorphism is implied in abnormalities of bone mineral density (BMD) in RA. We evaluated, in a case-control study performed in Mexican-Mestizo women with RA, whether SNP rs2073618 in the TNFRSF11B gene is associated with a decrease in BMD. RA patients were classified as follows: (1) low BMD and (2) normal BMD. All patients were genotyped for the rs2073618 polymorphism by PCR-RFLP. The frequency of low BMD was 74.4%. Higher age was observed in RA with low BMD versus normal BMD (62 and 54 years, resp.; p < 0.001). Worse functioning and lower BMI were observed in RA with low BMD (p = 0.003 and p = 0.002, resp.). We found similar genotype frequencies in RA with low BMD versus RA with normal BMD (GG genotype 71% versus 64.4%, GC 26% versus 33%, and CC 3% versus 2.2%, resp.; p = 0.6). We concluded that in Mexican-Mestizo female patients with RA, the rs2073618 polymorphism of the TNRFS11B gene is not associated with low BMD.
Keyphrases
- rheumatoid arthritis
- bone mineral density
- disease activity
- genome wide
- postmenopausal women
- ankylosing spondylitis
- interstitial lung disease
- body composition
- end stage renal disease
- copy number
- chronic kidney disease
- ejection fraction
- systemic lupus erythematosus
- newly diagnosed
- prognostic factors
- dna methylation
- gene expression
- healthcare
- systemic sclerosis
- patient reported outcomes
- mass spectrometry
- drug induced
- nuclear factor